Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Two flat cellular revertant cell lines, F-2 and C-11, which were originally selected from the DT line of Kirsten murine sarcoma virus (Ki-MuSV)-transformed NIH/3T3 cells, were examined for the production of transforming growth factors (TGFs). The revertant cells fail to grow in semisolid medium as colonies and exhibit a markedly reduced level of tumorigenicity in nude mice, although they are known to express high levels of p21ras, the product of the Kirsten sarcoma virus oncogene, ras, and they contain a rescuable transforming virus. TGF activity associated with the transformed, revertant, and non-transformed cell lines was measured by the ability of concentrated conditioned medium (CM) from these cells to induce normal rat kidney (NRK) and NIH/3T3 cells to form colonies in semisolid agar suspension cultures and to inhibit the binding of 125I epidermal growth factor (EGF) to specific cell surface receptors. CM from the transformed DT cells and from both the F-2 and C-11 revertants contains TGF activity, in contrast to CM obtained from normal NIH/3T3 cells. Furthermore, unlike NIH/3T3 cells, neither the DT nor the revertant cells were able to bind 125I EGF. All four cell lines were able to proliferate in serum-free medium supplemented with transferrin, insulin, EGF, and Pedersen fetuin. However, in basal medium lacking these growth factors, only DT cells and, to a lesser extent, the revertant cells were able to grow. These results suggest that the F-2 and C-11 revertants fail to exhibit all of the properties associated with transformation because the series of events leading to the transformed phenotype is blocked at a point(s) distal both to the expression of the p21 ras gene product and also to the production of TGFs and that the production of TGFs may be necessary but not sufficient for maintaining the transformed state.
D000818:Animals; D002448:Cell Adhesion; D002455:Cell Division; D002472:Cell Transformation, Viral; D004815:Epidermal Growth Factor / Q000378:metabolism; D066246:ErbB Receptors; D006133:Growth Substances / Q000096:biosynthesis*; D007708:Kirsten murine sarcoma virus; D051379:Mice; D009857:Oncogenes; D010452:Peptide Biosynthesis; D011956:Receptors, Cell Surface / Q000378:metabolism; D009053:Sarcoma Viruses, Murine; D012513:Sarcoma, Experimental / Q000235:genetics / Q000473:pathology*; D015291:Transforming Growth Factors
D006133:Growth Substances; D011956:Receptors, Cell Surface; D004815:Epidermal Growth Factor; D015291:Transforming Growth Factors; D066246:ErbB Receptors